{
    "2020-08-25": [
        [
            {
                "time": "",
                "original_text": "健帆生物：上半年净利润4.41亿元同比增44%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "净利润",
                        "同比增长",
                        "44%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)：上半年净利升44.11%至4.41亿元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "净利",
                        "上升",
                        "44.11%",
                        "4.41亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物：上半年净利润同比增长44.11%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "净利润",
                        "同比增长",
                        "44.11%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}